Organs‐on‐Chips in Clinical Pharmacology: Putting the Patient Into the Center of Treatment Selection and Drug Development
Year: 2019
Type: article
Abstract: There have been rapid advances since Organs-on-Chips were first developed. Organ-Chips are now available beyond academic laboratories with the initial emphasis to reduce animal experimentation and improve predictability of drug development through better prediction of safety and efficacy. There is now a huge opportunity to use chips to understand efficacy and disease variability. We propose that by 2030, Organs-on-Chips will play a key role in clinical pharmacology as part of the diagnostic and treatment workflow for some diseases by informing the right drug and dose regimen for each patient.
DOI: 10.1002/cpt.1688
Institutions: F. Hoffmann-La Roche AG, Emulate (United States)
Language: English
Subfield: Biomedical Engineering
Field: Engineering
Domain: Physical Sciences
Open Access status: hybrid
Estimated APC paid: $3,000
OpenAlex ID: W2991069968
